位置:首页 > 蛋白库 > KI16B_MOUSE
KI16B_MOUSE
ID   KI16B_MOUSE             Reviewed;        1312 AA.
AC   B1AVY7; O35056; Q3TUD2; Q6ZPM0; Q8BZZ9;
DT   31-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   08-APR-2008, sequence version 1.
DT   03-AUG-2022, entry version 116.
DE   RecName: Full=Kinesin-like protein KIF16B;
GN   Name=Kif16b; Synonyms=Kiaa1590;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 101-239.
RC   STRAIN=ICR;
RX   PubMed=9275178; DOI=10.1073/pnas.94.18.9654;
RA   Nakagawa T., Tanaka Y., Matsuoka E., Kondo S., Okada Y., Noda Y., Kanai Y.,
RA   Hirokawa N.;
RT   "Identification and classification of 16 new kinesin superfamily (KIF)
RT   proteins in mouse genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:9654-9659(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 195-1312.
RC   STRAIN=C57BL/6J; TISSUE=Gonad;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 487-1161.
RC   TISSUE=Embryonic tail;
RX   PubMed=14621295; DOI=10.1093/dnares/10.4.167;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: III.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:167-180(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1145, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-582 AND SER-838, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Kidney, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND INTERACTION WITH RAB14.
RX   PubMed=21238925; DOI=10.1016/j.devcel.2010.11.008;
RA   Ueno H., Huang X., Tanaka Y., Hirokawa N.;
RT   "KIF16B/Rab14 molecular motor complex is critical for early embryonic
RT   development by transporting FGF receptor.";
RL   Dev. Cell 20:60-71(2011).
CC   -!- FUNCTION: Plus end-directed microtubule-dependent motor protein
CC       involved in endosome transport and receptor recycling and degradation.
CC       Regulates the plus end motility of early endosomes and the balance
CC       between recycling and degradation of receptors such as EGF receptor
CC       (EGFR) and FGF receptor (FGFR). Regulates the Golgi to endosome
CC       transport of FGFR-containing vesicles during early development, a key
CC       process for developing basement membrane and epiblast and primitive
CC       endoderm lineages during early postimplantation development.
CC       {ECO:0000269|PubMed:21238925}.
CC   -!- SUBUNIT: Interacts with PTPN21 (By similarity). Interacts with RAB14.
CC       {ECO:0000250, ECO:0000269|PubMed:21238925}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q96L93}. Early endosome membrane
CC       {ECO:0000250|UniProtKB:Q96L93}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q96L93}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:Q96L93}. Note=It is unclear whether association
CC       with endosomes is mediated via phosphatidylinositol 3-phosphate
CC       (PtdIns(3)P)-binding or via its interaction with RAB14.
CC       {ECO:0000250|UniProtKB:Q96L93}.
CC   -!- DOMAIN: The PX domain mediates binding to phosphatidylinositol 3-
CC       phosphate (PtdIns(3)P), phosphatidylinositol 3,4-bisphosphate
CC       (PtdIns(3,4)P2), phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2)
CC       and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3). Does
CC       not bind phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) (By
CC       similarity). {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Embryonic death. Embryos are arrested at the
CC       blastocyst stage: the primitive endoderm and epiblast cannot be
CC       distinguished and appear as cell clumps resembling the inner cell mass
CC       (ICM) of the blastocyst. Embryos do not develop an epiblast epithelium
CC       and the uterine reaction appears to be incomplete. Development of the
CC       primitive endoderm and a basement membrane derived from it are severely
CC       affected in embryos at 4.5 dpc. {ECO:0000269|PubMed:21238925}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC98211.1; Type=Miscellaneous discrepancy; Note=Partially unspliced pre-RNA.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL731712; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731790; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL929136; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB001423; BAA22383.1; -; mRNA.
DR   EMBL; AK033018; BAC28130.2; -; mRNA.
DR   EMBL; AK160835; BAE36039.1; -; mRNA.
DR   EMBL; AK129401; BAC98211.1; ALT_SEQ; Transcribed_RNA.
DR   CCDS; CCDS38251.1; -.
DR   RefSeq; NP_001074602.1; NM_001081133.2.
DR   AlphaFoldDB; B1AVY7; -.
DR   SMR; B1AVY7; -.
DR   BioGRID; 200933; 3.
DR   STRING; 10090.ENSMUSP00000042551; -.
DR   iPTMnet; B1AVY7; -.
DR   PhosphoSitePlus; B1AVY7; -.
DR   EPD; B1AVY7; -.
DR   MaxQB; B1AVY7; -.
DR   PaxDb; B1AVY7; -.
DR   PeptideAtlas; B1AVY7; -.
DR   PRIDE; B1AVY7; -.
DR   ProteomicsDB; 263599; -.
DR   Antibodypedia; 24366; 108 antibodies from 16 providers.
DR   Ensembl; ENSMUST00000043589; ENSMUSP00000042551; ENSMUSG00000038844.
DR   GeneID; 16558; -.
DR   KEGG; mmu:16558; -.
DR   UCSC; uc008mpz.1; mouse.
DR   CTD; 55614; -.
DR   MGI; MGI:1098240; Kif16b.
DR   VEuPathDB; HostDB:ENSMUSG00000038844; -.
DR   eggNOG; KOG0245; Eukaryota.
DR   eggNOG; KOG2101; Eukaryota.
DR   GeneTree; ENSGT00940000162977; -.
DR   HOGENOM; CLU_001485_35_0_1; -.
DR   InParanoid; B1AVY7; -.
DR   OMA; HWHGAQQ; -.
DR   OrthoDB; 76316at2759; -.
DR   PhylomeDB; B1AVY7; -.
DR   TreeFam; TF105221; -.
DR   Reactome; R-MMU-2132295; MHC class II antigen presentation.
DR   Reactome; R-MMU-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-MMU-983189; Kinesins.
DR   BioGRID-ORCS; 16558; 6 hits in 73 CRISPR screens.
DR   ChiTaRS; Kif16b; mouse.
DR   PRO; PR:B1AVY7; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; B1AVY7; protein.
DR   Bgee; ENSMUSG00000038844; Expressed in submandibular gland and 255 other tissues.
DR   ExpressionAtlas; B1AVY7; baseline and differential.
DR   Genevisible; B1AVY7; MM.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; IEA:GOC.
DR   GO; GO:0005769; C:early endosome; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; ISS:UniProtKB.
DR   GO; GO:0005871; C:kinesin complex; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR   GO; GO:0045335; C:phagocytic vesicle; IDA:MGI.
DR   GO; GO:0005819; C:spindle; ISO:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0003777; F:microtubule motor activity; IBA:GO_Central.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0043325; F:phosphatidylinositol-3,4-bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0080025; F:phosphatidylinositol-3,5-bisphosphate binding; ISS:UniProtKB.
DR   GO; GO:0032266; F:phosphatidylinositol-3-phosphate binding; ISS:UniProtKB.
DR   GO; GO:0008574; F:plus-end-directed microtubule motor activity; ISS:UniProtKB.
DR   GO; GO:0031267; F:small GTPase binding; IPI:UniProtKB.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IDA:MGI.
DR   GO; GO:0045022; P:early endosome to late endosome transport; ISS:UniProtKB.
DR   GO; GO:0007492; P:endoderm development; IMP:UniProtKB.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0001704; P:formation of primary germ layer; IMP:UniProtKB.
DR   GO; GO:0006895; P:Golgi to endosome transport; IMP:UniProtKB.
DR   GO; GO:0007018; P:microtubule-based movement; IBA:GO_Central.
DR   GO; GO:0032801; P:receptor catabolic process; ISS:UniProtKB.
DR   GO; GO:0001919; P:regulation of receptor recycling; ISS:UniProtKB.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR000253; FHA_dom.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001683; PX_dom.
DR   InterPro; IPR036871; PX_dom_sf.
DR   InterPro; IPR008984; SMAD_FHA_dom_sf.
DR   PANTHER; PTHR24115; PTHR24115; 1.
DR   Pfam; PF00498; FHA; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   Pfam; PF00787; PX; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SMART; SM00312; PX; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
DR   PROSITE; PS50195; PX; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Coiled coil; Cytoplasm; Cytoskeleton; Endosome; Lipid-binding;
KW   Membrane; Microtubule; Motor protein; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transport.
FT   CHAIN           1..1312
FT                   /note="Kinesin-like protein KIF16B"
FT                   /id="PRO_0000409500"
FT   DOMAIN          3..358
FT                   /note="Kinesin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   DOMAIN          ?480..?544
FT                   /note="FHA"
FT   DOMAIN          1177..1291
FT                   /note="PX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00147"
FT   COILED          366..425
FT                   /evidence="ECO:0000255"
FT   COILED          835..913
FT                   /evidence="ECO:0000255"
FT   COILED          941..1073
FT                   /evidence="ECO:0000255"
FT   BINDING         102..109
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96L93"
FT   MOD_RES         577
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96L93"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         838
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1047
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96L93"
FT   MOD_RES         1145
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19144319"
SQ   SEQUENCE   1312 AA;  150058 MW;  4397E49FF4E93881 CRC64;
     MASVKVAVRV RPMNRREKDL EAKFIIQMEK SKTTITNLKI PEGGTGDSGR ERTKTFTYDF
     SFYSADTKSP DYVSQEMVFK TLGTDVVKSA FEGYNACVFA YGQTGSGKSY TMMGNSGDSG
     LIPRICEALF SRINETTRWD EASFRTEVSY LEIYNERVRD LLRRKSSKTF NLRVREHPKE
     GPYVEDLSKH LVQNYSDVEE LMDAGNINRT TAATGMNDVS SRSHAIFTIK FTQAKFDAEM
     PCETVSKIHL VDLAGSERAD ATGATGVRLK EGGNINKSLV TLGNVISALA DLSQDAANPL
     VKKKQVFVPY RDSVLTWLLK DSLGGNSKTI MIATISPADV NYGETLSTLR YANRAKNIIN
     KPTINEDANV KLIRELRAEI ARLKTLLAQG NQIALLDSPT ALSMEEKLHQ NEARVQELTK
     EWTNKWNETQ NILKEQTLAL RKEGIGVVLD SELPHLIGID DDLLSTGIIL YHLKEGQTYV
     GREDASTEQD IVLHGLDLES EHCVFENAGG TVTLIPLRGS QCSVNGVQIV DATQLNQGAV
     ILLGRTNMFR FNHPKEAAKL REKRKSGLLS SFSLSMTDLS KSCENLSAVM LYNPGLEFER
     QQREELEKLE SKRKLIEEME EKQKSDKAEL ERMQQEVETR RKETEIVQRQ IRKQEESLKR
     RSFHIENKLK DLLAEKERFE EERLREQQGL EQQRRQEEES LFRIREELRK LQELNSHEQA
     EKVQIFQELD RLHQEQNAQS AKLRLEKRRL EEEEKEQVQR VAHLEEQLRK RQDTAPLLCP
     GEAQRAQEEK RELESIREAL LQAKEMRAGG DHTCRDELER AQQYFLEFKR RQLVKLASLE
     KDLVQQKDLL SKEVQEEKVA LEHVKCDAGG DPSFLATDDG NILGGPPDLD KIKTAETRLQ
     SREHQLQDLL QNHLPALLEE KQRVLDALDS GVLGLDTTLC QVEKEVGEKE EQIAQYQANA
     SQLQQLRATF EFTANVARQE EKVRRKEKEI LESQEKQQRE ALEQAVAKLE QRRSALQRCS
     TLDLEIQEQR QKLGSLHTSE WSGWQASLET DGEALEMDPA RLEHEIHQLK QKICEVDGVQ
     RPHHGILEGQ AVLSSLPPSG GNSHLAPLMD ARISAYIEEE VQRRLHDLHR AIGDANHTPA
     DVMKSNEELH NGTTQRKLKY ERMYSRSLGT NRDDLKDPIK ISIPRYVLCG QGKDEHFEFE
     VKISVLDETW TVFRRYSRFR EMHKTLKLKY AELAALEFPP KKLFGNKDER VVAERRTHLE
     KYLREFFSVM LQSETSPLHI NKVGLTLSKH TICEFSPFFK KGVFDYSSHG TG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024